Walgreens Boots Alliance, Inc. (WBA) Revenue CAGR:6.22%(TTM)
Revenue CAGR uses precomputed financial statement history.
Over longer horizons, Walgreens Boots Alliance, Inc.'s Revenue CAGR averages 4.74% over 3 years and 3.53% over 5 years.The TTM figure compares the trailing 12 months (sum of the latest four quarters) with the 12 months before that. Rows in the history table compare fiscal years, and the quarterly table compares single quarters; the three measure different windows and will differ. Revenue CAGR measures how Walgreens Boots Alliance, Inc.'s top-line revenue has grown over time. Consistent revenue growth is a key indicator of business expansion and market share gains.
WBA Revenue CAGR Chart
Walgreens Boots Alliance, Inc. (WBA)
WBA Quarterly Revenue Growth (YoY)
Revenue growth vs the same quarter one year earlier, last 20 quarters.
WBA Revenue CAGR History
| Year | Start Revenue | End Revenue | Change | % Change | CAGR |
|---|---|---|---|---|---|
| 2024 | $139.08B | $147.66B | +$8.58B | +6.17% | +6.17% |
| 2023 | $132.70B | $139.08B | +$6.38B | +4.81% | +4.81% |
| 2022 | $132.51B | $132.70B | +$194.00M | +0.15% | +0.15% |
| 2021 | $121.98B | $132.51B | +$10.53B | +8.63% | +8.63% |
| 2020 | $120.07B | $121.98B | +$1.91B | +1.59% | +1.59% |
| 2019 | $131.54B | $120.07B | $-11.46B | -8.71% | -8.71% |
| 2018 | $118.21B | $131.54B | +$13.32B | +11.27% | +11.27% |
| 2017 | $117.35B | $118.21B | +$863.00M | +0.74% | +0.74% |
| 2016 | $103.44B | $117.35B | +$13.91B | +13.44% | +13.44% |
| 2015 | $76.39B | $103.44B | +$27.05B | +35.41% | +35.41% |
| 2014 | $72.22B | $76.39B | +$4.17B | +5.78% | +5.78% |
| 2013 | $71.63B | $72.22B | +$584.00M | +0.82% | +0.82% |
| 2012 | $72.18B | $71.63B | $-551.00M | -0.76% | -0.76% |
| 2011 | $67.42B | $72.18B | +$4.76B | +7.07% | +7.07% |
| 2010 | $63.34B | $67.42B | +$4.08B | +6.45% | +6.45% |
| 2009 | $59.03B | $63.34B | +$4.30B | +7.29% | +7.29% |
| 2008 | $53.76B | $59.03B | +$5.27B | +9.81% | +9.81% |
| 2007 | $47.41B | $53.76B | +$6.35B | +13.40% | +13.40% |
| 2006 | $42.20B | $47.41B | +$5.21B | +12.34% | +12.34% |
| 2005 | $37.51B | $42.20B | +$4.69B | +12.51% | +12.51% |
| 2004 | $32.51B | $37.51B | +$5.00B | +15.39% | +15.39% |
| 2003 | $28.68B | $32.51B | +$3.82B | +13.33% | +13.33% |
| 2002 | $24.62B | $28.68B | +$4.06B | +16.48% | +16.48% |
| 2001 | $21.21B | $24.62B | +$3.42B | +16.11% | +16.11% |
| 2000 | $17.84B | $21.21B | +$3.37B | +18.88% | +18.88% |
| 1999 | $15.31B | $17.84B | +$2.53B | +16.54% | +16.54% |
| 1998 | $13.36B | $15.31B | +$1.94B | +14.54% | +14.54% |
| 1997 | $11.78B | $13.36B | +$1.58B | +13.45% | +13.45% |
| 1996 | $10.40B | $11.78B | +$1.38B | +13.31% | +13.31% |
Quarterly Revenue: QoQ & YoY
| Quarter | Value | QoQ | YoY |
|---|---|---|---|
| Q3 2025 | $38.99B | +1.0% | +7.2% |
| Q2 2025 | $38.59B | -2.2% | +4.1% |
| Q1 2024 | $39.46B | +5.1% | +7.5% |
| Q4 2024 | $37.55B | +3.3% | +6.0% |
| Q3 2024 | $36.35B | -1.9% | +2.6% |
| Q2 2024 | $37.05B | +0.9% | +6.3% |
| Q1 2023 | $36.71B | +3.6% | +10.0% |
| Q4 2023 | $35.42B | +0.0% | +9.2% |
| Q3 2023 | $35.41B | +1.6% | +8.6% |
| Q2 2023 | $34.86B | +4.4% | +3.3% |
| Q1 2022 | $33.38B | +2.9% | -1.5% |
| Q4 2022 | $32.45B | -0.5% | -5.3% |
| Q3 2022 | $32.60B | -3.4% | -4.2% |
| Q2 2022 | $33.76B | -0.4% | +3.0% |
| Q1 2021 | $33.90B | -1.1% | +7.8% |
| Q4 2021 | $34.26B | +0.7% | -1.4% |
QoQ = change vs the prior quarter; YoY = change vs the same quarter a year earlier.
About Walgreens Boots Alliance, Inc.
Walgreens Boots Alliance, Inc., established in 1901 and based in Deerfield, Illinois, operates as a leading global retailer focused on pharmacy, health, and beauty products. Its business activities are organized into two primary divisions: the United States and International. In the United States, the company dispenses prescription drugs and offers a diverse selection of retail goods. This includes items for health, wellness, beauty, and personal care, alongside general merchandise and consumable products, all available through its extensive network of retail drugstores. The U.S. segment also provides specialized central pharmacy services and mail delivery options for prescriptions. As of August 31, 2021, this division managed 8,965 retail outlets under the Walgreens and Duane Reade banners, complemented by five specialty pharmacies. The International segment focuses on the sale of prescription medications, health and wellness items, beauty products, personal care essentials, and other consumer goods. These are sold through its pharmacy-centric health and beauty retail locations, optical practices, its online platform boots.com, and an integrated mobile application. Additionally, this segment engages in pharmaceutical wholesale and distribution operations within Germany. By August 31, 2021, the international portfolio included 4,031 retail stores operating under brands such as Boots, Benavides, and Ahumada, located across countries including the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile. It also oversaw 548 optical practices, with 160 of these operating as franchises.
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Timothy C. Wentworth